Immunomodulatory Drugs in Multiple Myeloma: Mechanisms of Action and Clinical Experience

Overview of attention for article published in Drugs, February 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (76th percentile)
Above-average Attention Score compared to outputs of the same age and source (63rd percentile)

Mentioned by

twitter: 3 X users

patent: 3 patents

Citations

dimensions_citation: 159 Dimensions

Readers on

mendeley: 243 Mendeley

Summary X Patents Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Methods of treating multiple myeloma with bispecific anti-BCMA x anti-CD3 antibodies

Grant US-11919965-B2

United States of America

COMPOSITIONS AND METHODS FOR SELECTIVE PROTEIN DEGRADATION

N/A TW-I829655-B

Chinese Taipei

Methods of Treating Multiple Myeloma with Bispecific Anti-BCMA x Anti-CD3 Antibodies

Application US-20210206865-A1

United States of America